Catalyst Wire Dossier Catalyst Wire Dossier

QLM3003 Ointment

· Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QLM3003 Ointment, covering 2025-03-12 to 2025-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis [Phase 3]

See pricing